Uncommon but Not Unknown: Efficacy of EGFR-TKIs for Uncommon Mutations - Q&A
In the Q&A session moderated by A/Prof Darren Lim, Prof. Yang answered important questions regarding tumour heterogeneity, resistance mechanisms of uncommon EGFR mutations and optimal treatment choices for specific populations harbouring uncommon EGFR mutations.
Speaker: Prof. James Chih-Hsin Yang
Document ID: PC-SG-100731
Speaker
Prof. James Chih-Hsin Yang
Distinguished Professor,
Director, Graduate Institute of Oncology
National Taiwan University,
Taiwan
Director, Department of Oncology
National Taiwan University Hospital,
Taiwan
Uncommon but Not Unknown: Efficacy of EGFR-TKIs for Uncommon Mutations
Speaker: Prof. James Chih-Hsin Yang
